Guardant Health Balance Sheet Health
Financial Health criteria checks 2/6
Guardant Health has a total shareholder equity of $68.3M and total debt of $1.1B, which brings its debt-to-equity ratio to 1670.4%. Its total assets and total liabilities are $1.7B and $1.6B respectively.
Key information
1,670.4%
Debt to equity ratio
US$1.14b
Debt
Interest coverage ratio | n/a |
Cash | US$1.03b |
Equity | US$68.29m |
Total liabilities | US$1.64b |
Total assets | US$1.70b |
Recent financial health updates
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Mar 29Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Nov 20Is Guardant Health (NASDAQ:GH) A Risky Investment?
Aug 15Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Apr 05Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Dec 28Here's Why Guardant Health (NASDAQ:GH) Can Afford Some Debt
Aug 15Recent updates
Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%
May 14Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Mar 29With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For
Jan 21Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Nov 20Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?
Sep 26A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)
Sep 05Is Guardant Health (NASDAQ:GH) A Risky Investment?
Aug 15A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)
May 28Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Apr 05Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Dec 28Guardant: Saving Lives One Blood Test At A Time
Oct 16Here's Why Guardant Health (NASDAQ:GH) Can Afford Some Debt
Aug 15Guardant Health's test gets FDA win for companion diagnostic to Enhertu's expanded use in lung cancer
Aug 12Guardant Health: Recent Developments Signal More Upsides
Jul 31Guardant Health: Pending Recession, May Hurt Cancer Care Demand
Jul 14Guardant Health (NASDAQ:GH) Is Carrying A Fair Bit Of Debt
Apr 29Guardant Health: Leaping Growth With Epic
Apr 14Financial Position Analysis
Short Term Liabilities: GH's short term assets ($1.3B) exceed its short term liabilities ($220.0M).
Long Term Liabilities: GH's short term assets ($1.3B) do not cover its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: GH's net debt to equity ratio (163.4%) is considered high.
Reducing Debt: GH's debt to equity ratio has increased from 0% to 1670.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GH has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if GH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.